Indication: 

The treatment of relapsed high-grade gliomas in children and adolescents.

The treatment of relapsed high-grade gliomas in combination with radiation therapy in adults.

The treatment of advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) with concurrent radiotherapy or chemoradiotherapy.